XML 52 R22.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHAREHOLDERS' EQUITY (DEFICIT)
9 Months Ended
Nov. 30, 2019
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' EQUITY (DEFICIT)

16. STOCKHOLDERS’ EQUITY (DEFICIT) 

 

Summary of Common Stock Activity 

 

On April 23, 2019 the Board of Directors approved an increase in authorized share capital to 5,000,000,000 shares of common stock and to change the par value of the common stock to $0.00001 per share. This became effective on June 20, 2019. The share capital has been retrospectively adjusted accordingly to reflect this change in par value. 

 

On April 23, 2019 the Board of Directors were granted approval to effectuate at its sole discretion a Reverse Stock Split of the Company’s Common Stock, by a ratio of no less than 2:1 and not more than 2000:1, with such ratio to be determined at the sole discretion of the Board and with the process to effect such Reverse Split to be commenced at any time, if at all, within a period of 6 months after May 31, 2019. On December 6, 2019 with shareholder approval, the Board of Directors authorized a 10:000:1 Reverse Split , which has of this filing date has not yet become effective

  

During the nine months ended November 30, 2019, the Company issued 3,651,425,069 shares of its common stock for the conversion of debt and related interest and fees totaling $492,608 including $373,062 of principal and $119,046 accrued interest, and $500 in fees in connection with debt converted during the period, as well as the release of the related derivative liability (see Note 15).

 

Summary of Stock Option Activity 

             
    Number of Warrants   Weighted Average Exercise Price   Weighted Average Remaining Years
             
Outstanding at March 1, 2019   20,436,309   $    0.01   2.81
Issued      
Exercised      
Forfeited and cancelled      
Outstanding at November 30, 2019   20,436,309   $    0.01   2.06

 

For the nine months ended November 30, 2019 and November 30, 2018, the Company recorded a total of $0 and $26,092, respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.